Your browser doesn't support javascript.
loading
RAS Mutations in Circulating Tumor DNA and Clinical Outcomes of Rechallenge Treatment With Anti-EGFR Antibodies in Patients With Metastatic Colorectal Cancer.
Sunakawa, Yu; Nakamura, Masato; Ishizaki, Masahiro; Kataoka, Masato; Satake, Hironaga; Kitazono, Masaki; Yanagisawa, Hideyuki; Kawamoto, Yasuyuki; Kuramochi, Hidekazu; Ohori, Hisatsugu; Nakamura, Michio; Maeda, Fumiyo; Komeno, Chihiro; Sonezaki, Tomoko; Takeuchi, Masahiro; Fujii, Masashi; Yoshino, Takayuki; Tsuji, Akihito; Ichikawa, Wataru.
Afiliação
  • Sunakawa Y; Department of Clinical Oncology, St Marianna University School of Medicine, Kawasaki, Japan.
  • Nakamura M; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan.
  • Ishizaki M; Department of Surgery, Japan Labour Health and Welfare Organization Okayama Rosai Hospital, Okayama, Japan.
  • Kataoka M; Department of Surgery, Nagoya Medical Center, Nagoya, Japan.
  • Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan.
  • Kitazono M; Department of Surgery, Nanpuh Hospital, Kagoshima, Japan.
  • Yanagisawa H; Department of Gastroenterology, Obihiro-Kosei General Hospital, Obihiro, Japan.
  • Kawamoto Y; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan.
  • Kuramochi H; Department of Chemotherapy, Tokyo Women's Medical University, Yachiyo Medical Center, Yachiyo, Japan.
  • Ohori H; Department of Medical Oncology, Ishinomaki Red Cross Hospital, Ishinomaki, Japan.
  • Nakamura M; Department of Gastroenterology, Sapporo City General Hospital, Sapporo, Japan.
  • Maeda F; Life Science Medical Affairs, Sysmex Corporation, Kobe, Japan.
  • Komeno C; Life Science Business Division, Gene Testing Business, Sysmex Corporation, Kobe, Japan.
  • Sonezaki T; Life Science Business Division, Gene Testing Business, Sysmex Corporation, Kobe, Japan.
  • Takeuchi M; Department of Clinical Medicine (Biostatistics), Kitasato University School of Pharmacy, Tokyo, Japan.
  • Fujii M; Japan Clinical Cancer Research Organization, Tokyo, Japan.
  • Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Tsuji A; Department of Clinical Oncology, Kagawa University Faculty of Medicine, Kagawa, Japan.
  • Ichikawa W; Division of Medical Oncology, Showa University Fujigaoka Hospital, Yokohama, Japan.
JCO Precis Oncol ; 4: 898-911, 2020 Nov.
Article em En | MEDLINE | ID: mdl-35050760
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão